$GNVR Balance Sheet | Understand Stock

$GNVR

$0.69 -$0.01 (1.43%) Close

$GNVR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Jun 30, 2026	Q2 FY2026 As of Mar 31, 2026	Q1 FY2026 As of Dec 31, 2025	Q4 FY2025 As of Sep 30, 2025	Q3 FY2025 As of Jun 30, 2025	Q3 FY2025 As of May 31, 2025	Q1 FY2025 As of Dec 31, 2024	Q4 FY2024 As of Sep 30, 2024	Q3 FY2024 As of Jun 30, 2024	Q2 FY2024 As of Mar 31, 2024	Q1 FY2024 As of Dec 31, 2023	Q4 FY2023 As of Sep 30, 2023	Q3 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Dec 31, 2022	Q2 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Sep 30, 2022	Q3 FY2022 As of Jun 30, 2022	Q2 FY2022 As of Mar 31, 2022	Q1 FY2022 As of Dec 31, 2021	Q4 FY2021 As of Sep 30, 2021
ASSETS
CURRENT ASSETS:
Cash
Prepaid expense
Prepaid costs for reverse capitalization
Other current assets
Total Current Assets

Property and equipment, net
Receivables from related parties
Deferred offering costs
Total Assets

LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Convertible notes payable, net of unamortized discount
Notes payable
Due to related party, shareholder
Interest payable
Accrued professional fees
Accrued research and development fees
Accrued payroll liability and compensation
Commercial loan
Financing liability
Accrued interest
Financed payable
Accrued interest on convertible notes payable
Accrued interest - related parties
Accounts payable and accrued expenses
Due To Related Party, Shareholder (note 5)
Due to related party
Accrued compensation and related expenses
Tax reimbursement policy liabilities (Note 8)
Advances from related parties
Related Party
Total advances from related parties
SBA loan
USDA CRADA liability
Total Current Liabilities

NON-CURRENT LIABILITIES:
Notes payable, long-term, net of $0 and $10,208 discount
Notes payable, net of discounts
Convertible notes payable, net of discounts
Total non-current liabilities
Warrant liabilities

Total Liabilities
Commitments and Contingencies (Note 8)
STOCKHOLDERS’ DEFICIT:
Preferred stock, value
Preferred Class B
Series B Preferred Stock
Total preferred stock, value

Common stock, $0.001 par value; 300,000,000 shares authorized; 36,675,786 and 30,175,763 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectively
Common stock to be issued, $0.001 par value; 265,666 and 0 shares to be issued at June 30, 2026 and September 30, 2025, respectively
Additional paid-in capital
Less: series B preferred stock held in treasury, at cost; 502,512 shares at June 30, 2026 and September 30, 2025, respectively
Accumulated deficit
Total Stockholders' Deficit
Total Liabilities and Stockholders' Deficit

Comments